These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6435628)
21. Direct quantitation of glycosaminoglycans in 2 mL of urine from patients with mucopolysaccharidoses. Burlingame RW; Thomas GH; Stevens RL; Schmid K; Moser HW Clin Chem; 1981 Jan; 27(1):124-8. PubMed ID: 6778634 [TBL] [Abstract][Full Text] [Related]
22. Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopolysaccharidoses. Taniguchi N; Miyawaki T; Moriya N; Okuda N Clin Chim Acta; 1975 May; 60(3):363-9. PubMed ID: 124636 [TBL] [Abstract][Full Text] [Related]
23. Tandem mass spectrometric assay of N-acetylglucosamine-6-sulfatase for multiplex analysis of mucopolysaccharidosis-IIID in dried blood spots. Liu Y; Gelb MH Mol Genet Metab; 2024 Jan; 141(1):108105. PubMed ID: 38128203 [TBL] [Abstract][Full Text] [Related]
25. Characterization of sulfated oligosaccharides in mucopolysaccharidosis type IIIA by electrospray ionization mass spectrometry. Mason KE; Meikle PJ; Hopwood JJ; Fuller M Anal Chem; 2006 Jul; 78(13):4534-42. PubMed ID: 16808463 [TBL] [Abstract][Full Text] [Related]
26. [Changes in urinary acid oligosaccharides after transfusion of normal plasma in 2 cases of Sanfilippo's syndrome]. Mainardi E; Moretti M; Calatroni A Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1540-6. PubMed ID: 4218490 [No Abstract] [Full Text] [Related]
27. Keratan and herparan sulfaturia: glucosamine-6-sulfate deficiency. Matalon R; Wappner R; Deanching M; Brandt IK; Horwitz A Ann Clin Lab Sci; 1982; 12(3):234-8. PubMed ID: 6212020 [TBL] [Abstract][Full Text] [Related]
28. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient. Gordon BA; Feleki V; Budreau CH; Tyler L Clin Biochem; 1975 Jun; 8(3):184-93. PubMed ID: 238759 [TBL] [Abstract][Full Text] [Related]
29. Sanfilippo D syndrome: correction of glucosamine-6-sulphatase deficiency following fibroblast culture in Chang's media. Freeman C; Hopwood JJ Prenat Diagn; 1991 Sep; 11(9):711-7. PubMed ID: 1788178 [TBL] [Abstract][Full Text] [Related]
30. Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A. Kresse H; Fuchs W; Glössl J; Holtfrerich D; Gilberg W J Biol Chem; 1981 Dec; 256(24):12926-32. PubMed ID: 6458607 [TBL] [Abstract][Full Text] [Related]
31. Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy. Downs-Kelly E; Jones MZ; Alroy J; Cavanagh KT; King B; Lucas RE; Baker JC; Kraemer SA; Hopwood JJ J Mol Neurosci; 2000 Dec; 15(3):251-62. PubMed ID: 11303788 [TBL] [Abstract][Full Text] [Related]
33. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome. Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800 [TBL] [Abstract][Full Text] [Related]
34. Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Ramsay SL; Meikle PJ; Hopwood JJ Mol Genet Metab; 2003 Mar; 78(3):193-204. PubMed ID: 12649064 [TBL] [Abstract][Full Text] [Related]
35. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. Hochuli M; Wüthrich K; Steinmann B NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120 [TBL] [Abstract][Full Text] [Related]
36. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623 [TBL] [Abstract][Full Text] [Related]
37. Mobilization of heparan sulfate induced by immunostimulation in a patient with mucopolysaccharidosis IIIA. Zerial M; Florio C; Dolzani L; Moro L; Romeo D Biochem Med; 1984 Apr; 31(2):228-35. PubMed ID: 6232924 [TBL] [Abstract][Full Text] [Related]
38. Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings. Cain H; Egner E; Kresse H Beitr Pathol; 1977 Apr; 160(1):58-72. PubMed ID: 405006 [TBL] [Abstract][Full Text] [Related]
39. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations. Jones MZ; Alroy J; Downs-Kelly E; Lucas RE; Kraemer SA; Cavanagh KT; King B; Hopwood JJ J Mol Neurosci; 2004; 24(2):277-91. PubMed ID: 15456941 [TBL] [Abstract][Full Text] [Related]
40. The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Hopwood JJ; Elliott H Clin Chim Acta; 1981 Apr; 112(1):67-75. PubMed ID: 6786804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]